Hollsteen
← CrowdStrike

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2019: $18.0M · 10-Q 0001558370-19-006161 filed Jul 19, 2019Research and development · Q2 FY2019: $19.0M · 10-Q 0001558370-19-008521 filed Sep 6, 2019Research and development · Q3 FY2019: $26.0M · 10-Q 0001535527-19-000011 filed Dec 6, 2019Research and development · Q4 FY2019: $22.0M · derived · 10-K 0001535527-20-000006 filed Mar 23, 2020Research and development · Q1 FY2020: $24.0M · 10-Q 0001558370-19-006161 filed Jul 19, 2019Research and development · Q2 FY2020: $32.0M · 10-Q 0001558370-19-008521 filed Sep 6, 2019Research and development · Q3 FY2020: $36.0M · 10-Q 0001535527-19-000011 filed Dec 6, 2019Research and development · Q4 FY2020: $39.0M · derived · 10-K 0001535527-21-000007 filed Mar 18, 2021Research and development · Q1 FY2021: $41.0M · 10-Q 0001535527-20-000012 filed Jun 3, 2020Research and development · Q2 FY2021: $50.0M · 10-Q 0001535527-20-000019 filed Sep 3, 2020Research and development · Q3 FY2021: $58.0M · 10-Q 0001535527-20-000025 filed Dec 3, 2020Research and development · Q4 FY2021: $66.0M · derived · 10-K 0001535527-22-000006 filed Mar 16, 2022Research and development · Q1 FY2022: $78.0M · 10-Q 0001535527-21-000013 filed Jun 4, 2021Research and development · Q2 FY2022: $90.0M · 10-Q 0001535527-21-000022 filed Sep 1, 2021Research and development · Q3 FY2022: $98.0M · 10-Q 0001535527-21-000028 filed Dec 2, 2021Research and development · Q4 FY2022: $105M · derived · 10-K 0001535527-23-000008 filed Mar 9, 2023Research and development · Q1 FY2023: $123M · 10-Q 0001535527-22-000012 filed Jun 3, 2022Research and development · Q2 FY2023: $138M · 10-Q 0001535527-22-000018 filed Aug 31, 2022Research and development · Q3 FY2023: $155M · 10-Q 0001535527-22-000025 filed Nov 30, 2022Research and development · Q4 FY2023: $192M · derived · 10-K 0001535527-24-000007 filed Mar 7, 2024Research and development · Q1 FY2024: $179M · 10-Q 0001535527-23-000014 filed Jun 1, 2023Research and development · Q2 FY2024: $179M · 10-Q 0001535527-23-000020 filed Aug 31, 2023Research and development · Q3 FY2024: $196M · 10-Q 0001535527-23-000026 filed Nov 29, 2023Research and development · Q4 FY2024: $214M · derived · 10-K 0001535527-25-000009 filed Mar 10, 2025Research and development · Q1 FY2025: $235M · 10-Q 0001535527-24-000013 filed Jun 5, 2024Research and development · Q2 FY2025: $251M · 10-Q 0001535527-24-000020 filed Aug 29, 2024Research and development · Q3 FY2025: $276M · 10-Q 0001535527-24-000026 filed Nov 27, 2024Research and development · Q4 FY2025: $314M · derived · 10-K 0001535527-26-000010 filed Mar 5, 2026Research and development · Q1 FY2026: $331M · 10-Q 0001535527-26-000025 filed Jun 4, 2026Research and development · Q2 FY2026: $343M · 10-Q 0001535527-26-000031 filed Aug 27, 2026Research and development · Q3 FY2026: $348M · 10-Q 0001535527-25-000033 filed Dec 3, 2025Research and development · Q4 FY2026: $356M · derived · 10-K 0001535527-26-000010 filed Mar 5, 2026Research and development · Q1 FY2027: $408M · 10-Q 0001535527-26-000025 filed Jun 4, 2026Research and development · Q2 FY2027: $444M · 10-Q 0001535527-26-000031 filed Aug 27, 2026missing22a44418Q1 FY2016Q2 FY2027Q4 FY2019
$MResearch and development · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2019: $18.0M · 10-Q 0001558370-19-006161 filed Jul 19, 2019Research and development · Q2 FY2019: $19.0M · 10-Q 0001558370-19-008521 filed Sep 6, 2019Research and development · Q3 FY2019: $26.0M · 10-Q 0001535527-19-000011 filed Dec 6, 2019Research and development · Q4 FY2019: $22.0M · derived · 10-K 0001535527-20-000006 filed Mar 23, 2020Research and development · Q1 FY2020: $24.0M · 10-Q 0001558370-19-006161 filed Jul 19, 2019Research and development · Q2 FY2020: $32.0M · 10-Q 0001558370-19-008521 filed Sep 6, 2019Research and development · Q3 FY2020: $36.0M · 10-Q 0001535527-19-000011 filed Dec 6, 201922a3618Q4 FY2018Q3 FY2020Q4 FY2019
Q4 FY2019
22a$M
derived
All values (34)
PeriodValue ($M)Status
Q2 FY2027444reported
Q1 FY2027408reported
Q4 FY2026356derived
Q3 FY2026348reported
Q2 FY2026343reported
Q1 FY2026331reported
Q4 FY2025314derived
Q3 FY2025276reported
Q2 FY2025251reported
Q1 FY2025235reported
Q4 FY2024214derived
Q3 FY2024196reported
Q2 FY2024179reported
Q1 FY2024179reported
Q4 FY2023192derived
Q3 FY2023155reported
Q2 FY2023138reported
Q1 FY2023123reported
Q4 FY2022105derived
Q3 FY202298reported
Q2 FY202290reported
Q1 FY202278reported
Q4 FY202166derived
Q3 FY202158reported
Q2 FY202150reported
Q1 FY202141reported
Q4 FY202039derived
Q3 FY202036reported
Q2 FY202032reported
Q1 FY202024reported
Q4 FY201922derived
Q3 FY201926reported
Q2 FY201919reported
Q1 FY201918reported

12 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for CrowdStrike

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$22.0M (derived)
Period
Q4 FY2019, ended Jan 31, 2019 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 85M − 63M = $22.0M (FY value from 10-K 0001535527-20-000006; 9-month value from the Q3-10-Q)
Source
10-K, filed Mar 23, 2020 · 0001535527-20-000006
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$22.0MMar 23, 202010-K 0001535527-20-000006derived · confidence 1. · current